Pictured: Oliver Zivanovic, Garrett Nash & Dennis Chi
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Friday, November 15, 2013

Memorial Sloan Kettering experts are leading investigations of a procedure called hyperthermic intraperitoneal chemotherapy, also known as HIPEC.

Pictured: Farid Boulad
Cancer Guide
By Celia Gittelson, BA  |  Thursday, November 14, 2013

Memorial Sloan Kettering specialists provide state-of-the-art care for a range of pediatric blood disorders.

Pictured: Mammogram
In the News
By Media Staff  |  Wednesday, November 13, 2013

Good Morning America reporter Amy Robach was diagnosed with breast cancer at age 40 after receiving her first mammogram. For Memorial Sloan Kettering experts, the message behind this story bears repeating: Mammograms save lives.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Wednesday, November 13, 2013

The study of some victims exposed to ionizing radiation from the 1986 Chernobyl nuclear power plant accident is yielding new information about how radiation-induced thyroid cancer develops.

Pictured: Sarat Chandarlapaty
In the Lab
By Jim Stallard, MA, Writer/Editor  |  Friday, November 8, 2013

Memorial Sloan Kettering researchers have found genetic mutations that cause some breast cancers to develop resistance to hormone therapy.

Pictured: Clifford Hudis
Video
By Memorial Sloan Kettering  |  Friday, November 1, 2013

Medical oncologist Clifford Hudis says advances in immunology and molecular biology are leading to remarkable successes in cancer treatment.

Pictured: Pierce McManus
Patient Story
By Andrea Peirce, BA, Writer/Editor  |  Thursday, October 31, 2013

His decision to go to Memorial Sloan Kettering taught marathon runner Pierce McManus about the power of a second opinion.

Pictured: Anas Younes, Chief, Lymphoma Service
Profile
By Jim Stallard, MA, Writer/Editor  |  Wednesday, October 30, 2013

Medical oncologist Anas Younes leads an ambitious effort to find disease biomarkers that could predict which lymphoma patients will benefit from new targeted therapies.

Pictured: Michael Zelefsky
In the Clinic
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, October 23, 2013

Memorial Sloan Kettering offers patients with prostate cancer a comprehensive package of the most advanced radiation therapy approaches that enable more-personalized and effective care.

Pictured: Leonard Saltz & Peter Bach
In the News
By Media Staff  |  Tuesday, October 22, 2013

Memorial Sloan Kettering experts question the high cost of cancer drugs in a New York Magazine cover story.

Cancer Care
Pictured: Mark Robson
Q&A
By Jim Stallard, MA, Writer/Editor  |  Monday, October 21, 2013

As genome sequencing of tumors becomes more routine, it increases the odds that additional disease-related mutations may be discovered by accident, a development that raises profound issues.

Pictured: Sergio Giralt & Robin Roberts
Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, October 17, 2013

Robin Roberts celebrated with more than 200 fellow stem cell transplant patients at Memorial Sloan Kettering’s annual Stem Cell Transplant Survivors Celebration.

Mouse glioblastoma tumor with phagocytic macrophages
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Tuesday, October 15, 2013

Memorial Sloan Kettering researchers say a drug that acts on noncancerous, tumor-infiltrating cells might provide a new treatment option for the most common and aggressive type of brain cancer.

Pictured: Lee Krug
Cancer Guide
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 11, 2013

Memorial Sloan Kettering is recognized worldwide for its treatment of pleural and peritoneal mesothelioma.

In the Community
By Esther Napolitano, BS, Science Writer/Editor  |  Thursday, October 10, 2013

Memorial Sloan Kettering leads a first-of-its-kind initiative to reduce cancer and cardiovascular health disparities among South Asian immigrants in the United States.

Center News

Stay Informed

Get the latest information about cancer care and research every month.